Order Article Reprints

Yu P-C, Huang C-H, Kuo C-J, Liang P-H, Wang LH-C, Pan MY-C, Chang S-Y, Chao T-L, Ieong S-M, Fang J-T, et al. Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Pharmaceutics. 2022; 14(1):176. https://doi.org/10.3390/pharmaceutics14010176

Yu, Pei-Chen, Chen-Hao Huang, Chih-Jung Kuo, Po-Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan, Sui-Yuan Chang, Tai-Ling Chao, Si-Man Ieong, Jun-Tung Fang, and et al. 2022. "Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets" Pharmaceutics 14, no. 1: 176. https://doi.org/10.3390/pharmaceutics14010176

Yu, P.-C., Huang, C.-H., Kuo, C.-J., Liang, P.-H., Wang, L. H.-C., Pan, M. Y.-C., Chang, S.-Y., Chao, T.-L., Ieong, S.-M., Fang, J.-T., Huang, H.-C., & Juan, H.-F. (2022). Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Pharmaceutics, 14(1), 176. https://doi.org/10.3390/pharmaceutics14010176